Learn about Atypical Hemolytic Uremic Syndrome Treatment in Turkey — how it works, who it is for, recovery timelines, and what to expect before and after surgery. Compare hospitals and doctors experienced in Atypical Hemolytic Uremic Syndrome and request assistance for cost estimates or appointments.

About Atypical Hemolytic Uremic Syndrome

Atypical Hemolytic Uremic Syndrome (aHUS) is a rare, life-threatening disease characterized by the abnormal destruction of red blood cells (hemolytic anemia), low platelet count (thrombocytopenia), and acute kidney injury. While primarily managed by nephrologists, a cardiologist plays a critical role when aHUS causes severe cardiovascular complications, such as malignant hypertension, heart failure, or thrombotic events affecting the heart. The cardiologist's procedure involves comprehensive cardiovascular assessment, monitoring, and intervention to manage these high-risk complications. This includes using advanced imaging, managing blood pressure crises, and providing supportive care to stabilize the patient's cardiac function while the underlying complement-mediated disease process is treated with targeted therapies like eculizumab or ravulizumab.

Key Highlights

    Critical for managing life-threatening cardiovascular complications of aHUS, such as severe hypertension and heart failure.Involves specialized monitoring and intervention to protect heart function during the acute disease phase.Works in a multidisciplinary team with nephrologists and hematologists for comprehensive patient care.Utilizes advanced cardiac imaging and monitoring techniques to assess damage and guide treatment.Aims to stabilize the patient's condition, allowing targeted therapy for the underlying complement disorder to be effective.

Who is this surgery for?

  • Patient diagnosed with aHUS presenting with severe, difficult-to-control hypertension (malignant hypertension).
  • Evidence of acute heart failure or cardiomyopathy secondary to aHUS.
  • Suspected cardiac involvement such as pericarditis or myocardial infarction due to microthrombi.
  • Need for intensive cardiovascular monitoring during plasma exchange or complement inhibitor infusion.
  • Assessment and management of cardiovascular risk factors exacerbated by the aHUS disease process.

How to prepare

  • Comprehensive review of the patient's aHUS diagnosis, lab results (including ADAMTS13 activity), and genetic testing.
  • Detailed cardiac evaluation including ECG, echocardiogram, and possibly cardiac MRI.
  • Strict monitoring and control of blood pressure using intravenous medications if necessary.
  • Coordination with the nephrology team regarding timing of plasma therapy or complement inhibitor doses.
  • Informed consent discussion focusing on the risks of cardiac procedures in the context of thrombocytopenia.
  • Preparation for potential need of intensive care unit (ICU) level monitoring.

Risks & possible complications

  • Worsening of heart failure or arrhythmias due to fluid shifts from plasma exchange or the disease itself.
  • Bleeding complications from invasive cardiac procedures due to underlying thrombocytopenia.
  • Risk of infection, especially if central venous access is required for monitoring or therapy.
  • Potential for hypertensive crisis or stroke if blood pressure is not meticulously controlled.
  • Adverse reactions to medications used for cardiovascular support.
  • Progression of kidney disease impacting cardiac management (e.g., fluid and electrolyte imbalances).

Recovery & hospital stay

  • Initial recovery involves close monitoring in a hospital setting, often in an ICU or cardiac step-down unit.
  • Blood pressure, fluid balance, and cardiac function are closely watched as complement inhibitor therapy takes effect.
  • Gradual weaning off intravenous cardiovascular medications as the patient stabilizes.
  • Long-term, ongoing cardiology follow-up is required to monitor for chronic hypertension or residual heart damage.
  • Recovery is closely tied to renal recovery; dialysis may be needed temporarily.
  • Patient education on monitoring blood pressure at home and recognizing symptoms of cardiac distress is essential.
  • checked Typical hospital stay: 7-14 days
  • checked Expected recovery time: Several weeks to months

Frequently Asked Questions

If you are considering atypical hemolytic uremic syndrome in Turkey, these questions and answers can help you make a confident, informed decision.

Procedure cost in other countries

Here is an overview of how the estimated cost, hospital stay, and recovery time for atypical hemolytic uremic syndrome compare across other countries where we have data.

Country Estimated cost range Typical stay Recovery time View details
India USD 1,652 – USD 5,506 7-14 days ~ Several weeks to months Know More
Turkey USD 12,293 – USD 40,978 7-14 days ~ Several weeks to months Know More

Top hospitals for Atypical Hemolytic Uremic Syndrome in Turkey

These partner hospitals in Turkey have dedicated cardiology teams and experience managing patients undergoing atypical hemolytic uremic syndrome.

  • Star
  • Star
  • Star
  • Star
  • Star
51+ Rating

Istinye Üniversitesi Hastanesi Liv

  • IconIstanbul, Turkey
  • Icon140 Doctors
  • Star
  • Star
  • Star
  • Star
  • Star
12+ Rating

Liv Hospital Ankara

  • IconIstanbul, Turkey
  • Icon140 Doctors
  • Star
  • Star
  • Star
  • Star
  • Star
112+ Rating

Liv Hospital Bahçeşehir

  • IconIstanbul, Turkey
  • Icon38 Doctors
PATIENT REVIEW

Emily Smith, a 42-year-old elementary school...

Emily Smith, a 42-year-old elementary school teacher and mother of two, had always been healthy. Her life changed after a severe bout of food poisoning. Weeks later, she developed debilitating fatigue, shortness of breath, and her urine turned dark. Her primary doctor found severe anemia and kidney injury, leading to a referral to a nephrologist who diagnosed Atypical HUS (aHUS). A cardiologist was consulted when an echocardiogram revealed her heart function was depressed, a rare but serious complication of the disease. The cardiologist, Dr. Chen, recommended immediate initiation of eculizumab, a targeted complement inhibitor, to halt the systemic damage attacking her blood vessels, kidneys, and heart. The treatment involved bi-weekly intravenous infusions. Emily was terrified, fearing for her life and her ability to care for her young children. The first infusion brought anxiety but no immediate side effects. Over the next few months, her energy slowly returned, her kidney function stabilized, and a repeat echo showed her heart function had significantly improved. Emotionally, she transitioned from sheer terror and helplessness to cautious optimism and profound gratitude. She now advocates for rare disease awareness, feeling she has been given a second chance at life with her family.

Cardiologists for Atypical Hemolytic Uremic Syndrome

Explore experienced cardiologists who regularly perform atypical hemolytic uremic syndrome and provide pre- and post-operative care in Turkey.

Dr. İlker Kolbaş
  • 7 Years Experience
  • Cardiologist
Speaks: English, Turkish
Consult Charge ₹ 15000
Available Today
December: 08:00 AM - 08:00 PM

MediFyr Plus Liv Hospital Ankara, Istanbul

OPD-desk synced • Updated
Dr. İlker Kolbaş
  • 7 Years Experience
  • Cardiologist
Speaks: English, Turkish
Consult Charge ₹ 15000
Available Today
December: 08:00 AM - 08:00 PM

MediFyr Plus Liv Hospital Ankara, Istanbul

OPD-desk synced • Updated
Dr. İlker Kolbaş
  • 7 Years Experience
  • Cardiologist
Speaks: English, Turkish
Consult Charge ₹ 15000
Available Today
December: 08:00 AM - 08:00 PM

MediFyr Plus Liv Hospital Ankara, Istanbul

OPD-desk synced • Updated
Dr. İlker Kolbaş
  • 7 Years Experience
  • Cardiologist
Speaks: English, Turkish
Consult Charge ₹ 15000
Available Today
December: 08:00 AM - 08:00 PM

MediFyr Plus Liv Hospital Ankara, Istanbul

OPD-desk synced • Updated
Dr. Lecturer İlker Kolbaş
  • 7 Years Experience
  • Cardiologist
Speaks: English, Turkish
Consult Charge ₹ 15000
Available Today
December: 08:00 AM - 08:00 PM

MediFyr Plus Liv Hospital Ankara, Istanbul

OPD-desk synced • Updated
Dr. Lecturer İlker Kolbaş
  • 7 Years Experience
  • Cardiologist
Speaks: English, Turkish
Consult Charge ₹ 15000
Available Today
December: 08:00 AM - 08:00 PM

MediFyr Plus Liv Hospital Ankara, Istanbul

OPD-desk synced • Updated
Dr. Lecturer İlker Kolbaş
  • 7 Years Experience
  • Cardiologist
Speaks: English, Turkish
Consult Charge ₹ 15000
Available Today
December: 08:00 AM - 08:00 PM

MediFyr Plus Liv Hospital Ankara, Istanbul

OPD-desk synced • Updated
Dr. Lecturer İlker Kolbaş
  • 7 Years Experience
  • Cardiologist
Speaks: English, Turkish
Consult Charge ₹ 15000
Available Today
December: 08:00 AM - 08:00 PM

MediFyr Plus Liv Hospital Ankara, Istanbul

OPD-desk synced • Updated
Dr. Lecturer İlker Kolbaş
  • 7 Years Experience
  • Cardiologist
Speaks: English, Turkish
Consult Charge ₹ 15000
Available Today
December: 08:00 AM - 08:00 PM

MediFyr Plus Liv Hospital Ankara, Istanbul

OPD-desk synced • Updated
Dr. Lecturer İlker Kolbaş
  • 7 Years Experience
  • Cardiologist
Speaks: English, Turkish
Consult Charge ₹ 15000
Available Today
December: 08:00 AM - 08:00 PM

MediFyr Plus Liv Hospital Ankara, Istanbul

OPD-desk synced • Updated
Dr. Lecturer İlker Kolbaş
  • 7 Years Experience
  • Cardiologist
Speaks: English, Turkish
Consult Charge ₹ 15000
Available Today
December: 08:00 AM - 08:00 PM

MediFyr Plus Liv Hospital Ankara, Istanbul

OPD-desk synced • Updated
Dr. Lecturer İlker Kolbaş
  • 7 Years Experience
  • Cardiologist
Speaks: English, Turkish
Consult Charge ₹ 15000
Available Today
December: 08:00 AM - 08:00 PM

MediFyr Plus Liv Hospital Ankara, Istanbul

OPD-desk synced • Updated